Infectious Disorders - Drug Targets

Aims & Scope

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes.

Each issue of the journal contains a series of timely in-depth reviews/mini-reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders.

As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.288

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	63

Journal Rank

Year	Value
2024	17033

Journal Citation Indicator

Year	Value
2024	392

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts

  Citation: 209

  Authors: Jean, Vincent, Gert, Edward, Wolfgang, Steven, Edward, Robert

• Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

  Citation: 191

  Authors: C., A., R.

• Overview of the Diagnosis of Cytomegalovirus Infection

  Citation: 185

  Authors: S., Z., S., S.

• Plasmodium Dihydroorotate Dehydrogenase: A Promising Target for Novel Anti-Malarial Chemotherapy

  Citation: 185

  Authors: Margaret, Pradipsinh

• HAART in HIV/AIDS Treatments: Future Trends

  Citation: 143

  Authors: Da-Yong, Hong-Ying, Nagendra Sastry, Bin, Jian, Ting-Ren

• A Review on Free Radicals and Antioxidants

  Citation: 135

  Authors: Hourieh

• The Implication of Platelet Activating Factor in Cancer Growth and Metastasis: Potent Beneficial Role of PAF-Inhibitors and Antioxidants

  Citation: 133

  Authors: A., C., C., C.

• Potential Roles of Histones in Host Defense as Antimicrobial Agents

  Citation: 132

  Authors: H., S.

• Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

  Citation: 129

  Authors:

• Phospho-MurNAc-Pentapeptide Translocase (MraY) as a Target for Antibacterial Agents and Antibacterial Proteins

  Citation: 119

  Authors: Timothy, Adrian, David

---